Advertisement

Topics

Neuronix seeks FDA approval for its therapy system

06:06 EST 1 Dec 2016 | Medical Business Review

Neuronix has announces positive results from its pivotal, double-blind placebo-controlled, multi-center clinical study, for the assessment of safety and efficacy of the neuroAD therapy system, in the treatment of mild to moderate Alzheimer's disease.

Original Article: Neuronix seeks FDA approval for its therapy system

NEXT ARTICLE

More From BioPortfolio on "Neuronix seeks FDA approval for its therapy system"

Quick Search
Advertisement
 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...